Development of the method for the identification of treatment resistance using hypoxia PET

Development of the method for the identification of treatment resistance using hypoxia PET - Identification of treatment resistance using hypoxia PET

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029884

Enrollment

100

Registered

2017-11-10

Start date

2017-11-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer, lung cancer

Interventions

injection of PET tracer(one day, single time)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.patients with head and neck cancer 2.patients equal to or older than 20 years old 3.Patient who got written informed consent

Exclusion criteria

Exclusion criteria: 1.Lesion has already been surgically resected 2.Breast-feeding, pregnant women, patients wishing for pregnancy 3.Patients judged as not appropriate by researchers

Design outcomes

Primary

Measure	Time frame
Presence of hypoxic area and time to recurrence in head and neck cancer and lung cancer.	—

Secondary

Measure	Time frame
1) Hypoxic area and PSF, OS 2) Change in tumor marker 3) hypoxic area and LN metastasis, distant metastasis	—

Countries

Japan

Contacts

Public ContactShingo Baba

kyushu University Hospital department of radiology

sbaba127@radiol.med.kyushu-u.ac.jp0926425695

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026